LeukemiaTexas awards grants for research to enhance the understanding of leukemia and its cause, to develop new and improved methods of treatment and ultimately to find a cure for this life-threatening blood cancer. All grants are awarded to Texas nonprofit institutions for research conducted in Texas.
Through its Research program, LeukemiaTexas also offers a Young Investigator award. This award helps fulfill a major need in today's scientific research community by funding innovative research by promising young researchers at the early stages of their careers. $1,125,000 in Young Investigator grants have been awarded in recent years.
Over the past few years, LeukemiaTexas awarded 3 new research grants totaling $450,000 for research conducted at The University of Texas Southwestern Medical Center (Dallas), The University of Texas MD Anderson Cancer Center (Houston) and UT Health Science Center at San Antonio. Two of these grants were Young Investigator awards.
Results from research made possible by $1,529,391 of recent LeukemiaTexas grants have been internationally recognized. These results have been published in the Journal of the American Medical Association, Lancet, Proceedings of the National Academy of Science, Journal of Clinical Oncology, Tissue Antigens, Biology of Blood and Marrow Transplantation and Hematology/Oncology Clinics of North America.
This research has also been presented at the American Society of Hematology Annual Conference, National Marrow Donor Program Conference, the 18th Annual HLA Advanced Technical Workshop, the 13th Annual Conference on the Gene Therapy of Cancer and the 48th Annual Meeting of the American Society of Hematology. Interested research institutions and researchers may contact LeukemiaTexas for more information about the LeukemiaTexas Research Grant Program.